Invention Grant
- Patent Title: HER3 specific monoclonal antibodies for diagnostic and therapeutic use
-
Application No.: US14774808Application Date: 2014-03-13
-
Publication No.: US09725520B2Publication Date: 2017-08-08
- Inventor: Ningyan Zhang , Zhiqiang An
- Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2014/025446 WO 20140313
- International Announcement: WO2014/159915 WO 20141002
- Main IPC: C07K16/32
- IPC: C07K16/32 ; G01N33/574 ; A61F7/10 ; A61K39/395 ; A61K45/06 ; A61N5/10 ; A61K39/00
Abstract:
Isolated or recombinant anti-HER3 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.
Public/Granted literature
- US20160032011A1 HER3 SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE Public/Granted day:2016-02-04
Information query
